May 13, 2021 01:41 PM EDTUpdated 02:15 PM

Vaccine maker Northwest Bio claims it's in the homestretch for its manufacturing expansion in the UK

Josh Sullivan

While the last 2 years have been a roller coaster for Maryland-based vaccine maker Northwest Biotherapeutics — highlighted by a $250,000 fine from the SEC, years …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Vaccine maker Northwest Bio claims it's in the homestretch for its manufacturing expansion in the UK

Josh Sullivan

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Vac­cine mak­er North­west Bio claims it's in the home­stretch for its man­u­fac­tur­ing ex­pan­sion in the UK

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Vaccine maker Northwest Bio claims it's in the homestretch for its manufacturing expansion in the UK